Neil Exter's most recent trade in Decibel Therapeutics Inc was a trade of 10,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 17, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Decibel Therapeutics Inc | Neil Exter | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Revolution Medicines Inc | Neil Exter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 18,400 | 18,400 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Neil Exter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Revolution Medicines Inc | Neil Exter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 5,200 | 28,815 (0%) | 0% | 0 | Common Stock | |
| Pliant Therapeutics Inc | Neil Exter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 13,286 | 13,286 | - | - | Stock Option (right to buy) | |
| Revolution Medicines Inc | Neil Exter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 12,659 | 12,659 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Neil Exter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 3,617 | 23,615 (0%) | 0% | 0 | Common Stock | |
| Decibel Therapeutics Inc | Neil Exter | Director, Ten Percent Owner | 17 Feb 2021 | 45,638,882 | 0 | - | - | Series A Preferred Stock | ||
| Decibel Therapeutics Inc | Neil Exter | Director, Ten Percent Owner | 17 Feb 2021 | 2,938,945 | 2,986,114 | - | - | Common Stock | ||
| Decibel Therapeutics Inc | Neil Exter | Director, Ten Percent Owner | 17 Feb 2021 | 1,250,000 | 0 | - | - | Series C Preferred Stock | ||
| Decibel Therapeutics Inc | Neil Exter | Director, Ten Percent Owner | 17 Feb 2021 | 289,603 | 0 | - | - | Series D Preferred Stock | ||
| Decibel Therapeutics Inc | Neil Exter | Director, Ten Percent Owner | 17 Feb 2021 | 98,929 | 3,085,043 | - | - | Common Stock | ||
| Decibel Therapeutics Inc | Neil Exter | Director, Ten Percent Owner | 17 Feb 2021 | 54,642 | 3,139,685 | - | - | Common Stock | ||
| Decibel Therapeutics Inc | Neil Exter | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 20,000 | 20,000 | - | - | Stock Option(right to buy) |